CHAPTER 1_ Imaging & Physiology

1.
Imaging
① OCT optical coherence tomography 2
② IVUS (NIRS) intravascular ultrasound 26
2.
Physiology
① FFR fractional flow reserve 68
② IMR (microvascular resistance index), CFR (coronary flow reserve),
Non-hyperaemic pressure ratios (NHPR) 88

CHAPTER 2_ Special Device modalities

1. ROTA Rotational Atherosclerosis Removal 100
2. ECMO Extracorporeal Membrane Oxygenation Device 118
3. PCC (Pericardiocentesis) pericardial puncture 142
4. TPM (Temporary Pacemaker) 145
5.
Cardioversion & Defibrillation 156
6. EMB (Endomyocardial Biopsy) 161

CHAPTER 3_ SHD (Structural Heart Disease)

1. Congenital heart disease (ASD, PFO, PDA, LAAO)
① Atrial Septal Defect (ASD) &
Patent Foramen Ovale (PFO) 166
② Patent Ductus Arteriosus (PDA) 179
③ Left Atrial Appendage Occlusion (LAAO) 189
2. TAVI (Edward, Medronic, Boston) transcatheter aortic valve replacement 199
3. ICE intracardiac ultrasound 229

CHAPTER 4_ Peripheral Intervention

1. EVAR & TEVAR Abdominal/Thoracic Aortic Stenting 252
2. Percutaneous Transluminal Angioplasty (PTA) Peripheral Vascular Intervention 263
3.
Peripheral Device (JETSTREAM, Hawk One, NGIOJET) 281
4.
Closing Device(Perclose Prostyle, Femoseal, Mynx, Exoseal, Angioseal…) 297

CHAPTER 5_ Cardiac Catheterization

1.
Cardiac catheterization 310
2. CTEPH & BPA Chronic Thromboembolic Pulmonary Hypertension 319

CHAPTER 6_ Interventional cardiovascular nursing

1. CAG (Coronary Angiography) Coronary Angiography 326
2. PCI (Percutaneous Coronary Intervention) 337
3. CAG, PCI Benefit Standards (Method for Calculating Nursing Benefit Costs) 345
4.
Spasm Provocation Test 362

CHAPTER 7_ Procedural complications

1.
No reflow phenomenon 370
2.
Coronary artery perforation 374
3.
Coronary artery dissection and acute closure 378
4.
Local vascular complications 382
5.
Acute myocardial infarction Fast track (C★) and CPCR 386
6.
Unstable vital signs 390
7.
Transfusion reaction 396
8.
Contrast media reactions 400
9.
Contrast-Induced Nephropathy 404
10. CAG & PCI Complications 407

CHAPTER 8_ Cardiovascular Drugs

1.
Anticoagulant agents 416
2.
Antiplatelet agents 421
3. DAPT (Dual Antiplatelet Therapy) 428
4.
Thrombolytic agents 435
5.
Anti-ischemic therapy 440

Index / 446

Revising the Korean Society for Cardiovascular Technology Textbook...

This revised edition of the “KCTA Cardiovascular Intervention Manual” has been compiled and revised to provide comprehensive, up-to-date information on cardiovascular diseases and procedures, which occupy a significant position in modern medicine.

In an effort to advance cutting-edge technology and research in the cardiovascular field, this book has been revised to ensure that radiologists, clinical pathologists, nurses, and students interested in this field can access and apply the latest information.

This revised edition is truly a masterpiece, a result of three years of passionate dedication from physicians working in cardiovascular procedure rooms across the country, who shared decades of expertise. It's a profound honor to publish this revised edition after the first edition of the KCTA Cardiovascular Intervention Manual.

I would like to express my sincere gratitude to each and every one of the authors who collected and organized the data, and once again to all the staff at Woori Medical Books Publishing who contributed to the publication of this book.

I hope this book will be helpful to all readers, and I express my respect and gratitude to the editors and contributors.

January 10, 2025
President of the Korean Society of Cardiovascular Technology
Kang Jun-won